This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Regulus Therapeutics Inc (RGLS)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 15.96M 37.33M 17.81M 40.55M
Receivables 10.02M 274.00K 79.00K 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 759.00K 0.00 0.00 0.00
Total Current Assets 134.26M 164.95M 117.18M 98.93M
Property, Plant & Equipment, Gross 11.85M 8.72M 7.50M 5.75M
Accumulated Depreciation & Depletion 6.45M 5.15M 3.73M 2.44M
Property, Plant & Equipment, Net 5.40M 3.57M 3.77M 3.31M
Intangibles 1.08M 1.15M 1.13M 1.15M
Other Non-Current Assets 344.00K 1.81M 987.00K 125.00K
Total Non-Current Assets 6.83M 6.53M 5.88M 4.59M
Liabilities & Shareholder Equity
Total Assets 141.08M 171.48M 123.06M 103.52M
Accounts Payable 2.72M 2.19M 1.17M 311.00K
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 12.63M 35.19M 10.37M 12.77M
Long Term Debt 0.00 0.00 11.28M 10.13M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 4.37M 4.27M 7.96M 18.52M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 4.37M 4.27M 19.24M 28.66M
Total Liabilities 17.00M 39.47M 29.61M 41.42M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 124.08M 132.01M 93.46M 62.09M
Common Par 53.00K 49.00K 42.00K 36.00K
Additional Paid In Capital 315.67M 267.93M 172.52M 122.53M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -191.51M -135.77M -79.09M -60.42M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -133.00K -197.00K -16.00K -52.00K
Total Capitalization 124.08M 132.01M 104.74M 72.23M
Total Equity 124.08M 132.01M 93.46M 62.09M
Total Liabilities & Stock Equity 141.08M 171.48M 123.06M 103.52M
Total Common Shares Outstanding 52.67M 48.94M 41.79M 35.83M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 51.41M 44.09M 38.48M 8.21M
Diluted Weighted Shares Outstanding 51.41M 44.09M 38.48M 8.21M
Number of Employees 88 81 76 66
Number of Part-Time Employees 4 4 0 6
RGLS News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

RGLS Regulus Therapeutics Inc

Chart of RGLS

Analysts Ratings for RGLS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 7 5 5 5
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET RGLS ANALYST REPORT

RGLS Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs